Evelyn Jackson

CMS Issues The Long-Awaited Medicaid Drug Rebate Program Final Rule, With Fewer Changes Than Anticipated

ORI Issues Final Changes To Research Misconduct Regulations: Key Reforms And Lingering Complexities

Fall 2023 Federal Government Shutdown: Possible Effects On The Health Care Industry

Continued Agency Strides Towards IRA Negotiation Program Implementation: CMS Issues Final Guidance On The 2026 Inflation Reduction Act Medicare Part D Negotiation Process

A New Wave Of Agency Action Around Drug Pricing: CMS Proposes Sweeping Medicaid Drug Rebate Program Rule